Home›Legal›BPC-157 in Florida
BPC-157 in Florida: Legal Status & Provider Guide (2026)
Quick Answer
BPC-157 is a prescription substance in the United States. BPC-157 has no FDA-approved drug application. It is classified as a research peptide and cannot be compounded by 503A/503B pharmacies under current federal guidance. Clinical use in the U.S. occurs in a legal gray area — consult a healthcare attorney and licensed prescriber for current federal standing. In Florida, compounding is governed by the Florida Board of Pharmacy (FBP). In Florida, advanced practice registered nurses (APRNs) with prescriptive authority and physician assistants may prescribe compounded peptides within the scope of their collaborative agreement. Florida's telehealth laws permit prescribing without prior in-person visit in many contexts, which has made Florida a hub for telehealth peptide programs. Prescribers must hold a Florida license to prescribe to Florida patients.
Federal Legal Status
FDA Approval Status
Not FDA-approved as a drug. Not on any FDA bulk substances list for compounding.
Compounding Pharmacy Rules (Federal)
BPC-157 is not on the FDA 503A or 503B bulk substances lists, meaning licensed compounding pharmacies cannot legally compound it for individual patients under federal law. Its status as a bulk substance for compounding has been contested and remains legally uncertain. Some providers offer it under state-level regulatory frameworks, but federal compliance risk is elevated.
Also Known As
Body Protection Compound 157 · PL 14736
Primary Research Areas
- Tissue repair
- Gut health
- Tendon and ligament healing
- Angiogenesis
Florida Pharmacy Board & Compounding Rules
Regulator
Compounding Overview
Florida has a large and active compounding pharmacy sector. The Florida Board of Pharmacy (Department of Health) regulates sterile and non-sterile compounding, requiring separate permits for each type. Florida pharmacies that compound sterile preparations must comply with USP 797 and undergo periodic inspections. Florida has specific rules for "office use" compounding — a provision that allows prescribers to order pre-mixed sterile compounds for use in their offices, which is relevant to many peptide clinics.
Notable Rules
- Florida requires separate permits for sterile and non-sterile compounding.
- Florida allows "office use" compounding with specific restrictions — relevant to many peptide clinical practices.
- USP 797 compliance is mandatory for all sterile compounding facilities.
- Florida telehealth laws are permissive by national standards, making the state a major market for telehealth peptide programs.
- Out-of-state pharmacies must be registered with the Florida Board of Pharmacy to ship into the state.
Prescribing Requirements in Florida
In Florida, advanced practice registered nurses (APRNs) with prescriptive authority and physician assistants may prescribe compounded peptides within the scope of their collaborative agreement. Florida's telehealth laws permit prescribing without prior in-person visit in many contexts, which has made Florida a hub for telehealth peptide programs. Prescribers must hold a Florida license to prescribe to Florida patients.
About BPC-157
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. It has been studied in animal models for tissue repair, gut protection, and angiogenesis. No completed Phase III human trials exist as of 2026.
For more research information, mechanism of action, and provider availability, see the BPC-157 research profile on PeptideBase.
Frequently Asked Questions
- Is BPC-157 legal in the United States?
- BPC-157 exists in a legal gray area. It is not FDA-approved and is not on the 503A/503B bulk compounding lists. Research-use possession is generally not a federal crime, but commercial sale and compounding for human use carry significant legal risk.
- Can a doctor prescribe BPC-157?
- A licensed prescriber may write an order for BPC-157, but compounding pharmacies subject to FDA oversight cannot legally compound it. Some providers operate under state regulations or as research programs. Patients should consult both a physician and legal counsel.
BPC-157 Providers in Florida
No providers currently listed in Florida for BPC-157. Browse the full directory to find providers offering BPC-157.
Browse all BPC-157 providers →BPC-157 Legal Status in Other States
Pharmacy board rules and compounding regulations vary by state. Compare BPC-157 legal status across other major markets:
Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .